Literature DB >> 16200600

Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.

Yalei Wu1, Jianzhong Liu, Xu Feng, Pingar Yang, Xin Xu, Hui-Chen Hsu, John D Mountz.   

Abstract

OBJECTIVE: Erosion of cartilage and bone is a hallmark of rheumatoid arthritis (RA). This study was undertaken to explore the roles of hyperproliferating synovial fibroblasts and macrophages in abnormal osteoclast formation, using the recently described BXD2 mouse model of RA.
METHODS: Cell distribution in the joints was analyzed by immunohistochemistry, using tartrate-resistant acid phosphatase (TRAP) staining to identify osteoclasts. To identify the defective cells in BXD2 mice, mouse synovial fibroblasts (MSFs) were cultured with bone marrow-derived macrophages. Osteoclast formation was assayed by TRAP staining and bone resorption pit assay, and the cytokine profiles of the MSFs and macrophages were determined by quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay.
RESULTS: In BXD2 mice, TRAP-positive osteoclasts were found at sites of active bone erosion, in close proximity to hyperproliferating synovial fibroblasts. On coculture, MSFs from BXD2 mice, but not C57BL/6 mice, produced high levels of RANKL messenger RNA, induced macrophages to form osteoclasts, and actively eroded bone slices, through a mechanism(s) that could be blocked by pretreatment with osteoprotegerin. Although macrophages from BXD2 mice expressed higher basal levels of tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), and IL-6 than those from C57BL/6 mice, abnormal osteoclast formation was not due to enhanced sensitivity of the BXD2 mouse macrophages to RANKL. TNFalpha, produced by both BXD2 MSFs and BXD2 mouse macrophages, had a strong stimulatory effect on RANKL expression.
CONCLUSION: BXD2 MSFs produce RANKL and induce the development of osteoclasts from macrophages. The enhanced production of RANKL is possibly due to autocrine stimulation, together with paracrine stimulation by factors produced by macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200600     DOI: 10.1002/art.21354

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  17 in total

1.  Treatment of arthritis by macrophage depletion and immunomodulation: testing an apoptosis-mediated therapy in a humanized death receptor mouse model.

Authors:  Jun Li; Hui-Chen Hsu; PingAr Yang; Qi Wu; Hao Li; Laura E Edgington; Matthew Bogyo; Robert P Kimberly; John D Mountz
Journal:  Arthritis Rheum       Date:  2011-10-13

Review 2.  Rheumatology practice in Japan: challenges and opportunities.

Authors:  Kenji Oku; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2019-03-19       Impact factor: 2.631

3.  Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes.

Authors:  Y Li; D Li; Y Li; S Wu; S Jiang; T Lin; L Xia; H Shen; J Lu
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

4.  Involution of collagen-induced arthritis with an angiogenesis inhibitor, PPI-2458.

Authors:  Ernest Brahn; Nathan Schoettler; Sarah Lee; Mona L Banquerigo
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

5.  IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis.

Authors:  Seon-Yeong Lee; Young Ok Jung; Doo-Jin Kim; Chang-Min Kang; Young-Mee Moon; Yu-Jung Heo; Hye-Jwa Oh; Seong-Jeong Park; Se-Hwan Yang; Seung Ki Kwok; Ji-Hyeon Ju; Sung-Hwan Park; Young Chul Sung; Ho-Youn Kim; Mi-La Cho
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

6.  Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis.

Authors:  X Xu; H-C Hsu; J Chen; W E Grizzle; W W Chatham; C R Stockard; Q Wu; P A Yang; V M Holers; J D Mountz
Journal:  Scand J Immunol       Date:  2009-09       Impact factor: 3.487

7.  Death receptor 5-targeted depletion of interleukin-23-producing macrophages, Th17, and Th1/17 associated with defective tyrosine phosphatase in mice and patients with rheumatoid arthritis.

Authors:  Jun Li; PingAr Yang; Qi Wu; Hao Li; Yanna Ding; Hui-Chen Hsu; David M Spalding; John D Mountz
Journal:  Arthritis Rheum       Date:  2013-10

8.  Inhibition of fucosylation reshapes inflammatory macrophages and suppresses type II collagen-induced arthritis.

Authors:  Jun Li; Hui-Chen Hsu; Yana Ding; Hao Li; Qi Wu; PingAr Yang; Bao Luo; Amber L Rowse; David M Spalding; S Louis Bridges; John D Mountz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

9.  BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.

Authors:  Balint Farkas; Ferenc Boldizsar; Oktavia Tarjanyi; Anna Laszlo; Simon M Lin; Gabor Hutas; Beata Tryniszewska; Aaron Mangold; Gyorgy Nagyeri; Holly L Rosenzweig; Alison Finnegan; Katalin Mikecz; Tibor T Glant
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

10.  Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.

Authors:  Jeong Yeon Kim; Eun Young Lee; Eun Bong Lee; Yun Jong Lee; Hyun Jung Yoo; Jiyong Choi; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2012-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.